 September 2020:

Our latest paper is out! Fantastic collaboration with Olivier Devuystâ€™s lab at the University of Zurich. Alpelisib rescues actin phenotypes and endocytic uptake in OCRL deficient cells and improves proteinuria in the mouse model of Lowe syndrome/Dent disease 2. Featured in Business Weekly, Cambridge Network and EurekAlert
